Carolina Blaya Dreher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carolina Blaya Dreher has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Alice Castro Menezes Xavier
Universidade de São Paulo image/svg+xml
5 shared publications - Gisele Gus Manfro
Anxiety Disorder Program, Hospital de Clínicas de Porto Alegre, Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
3 shared publications - Camila Maria Barbieri de Souza
Medical School, Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil
2 shared publications - Cecilia Cassal
Service of Dermatology, Ambulatório de Dermatologia Sanitária, Rio Grande do Sul, RS, Brazil
2 shared publications - Clarissa Prati
Instituto de Assistência Médica ao Servidor Público Estadual, São Paulo, SP, Brazil
2 shared publications - Giovanni Abrahão Salum
Child Mind Institute, New York, NY 10022, USA
2 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by FapUNIFESP (SciELO) in SciELO Preprints
Integrating a self-guided cognitive behavioral therapy app (CONEMO) into Brazilian primary health care: protocol for a hybrid type III implementation-effectiveness study
Background: Depression and anxiety are common and disabling mental health conditions. Although cognitive behavioral therapy (CBT) is an evidence-based treatment, access remains limited, particularly in low- and middle-income countries. Internet-delivered CBT (iCBT) may expand access to psychological interventions, but integrating digital interventions into routine primary care remains challenging. This study protocol describes the implementation of CONEMO (Emotional Control), a self-guided iCBT app for depression and anxiety symptoms, in primary care units in 2 municipalities in Brazil. Methods: This mixed-methods hybrid type III implementation-effectiveness study is being conducted in primary care units in Indaiatuba and Jaguariúna, São Paulo, Brazil. Adults screening positive for depression (Patient Health Questionnaire-9 score ≥10) or anxiety (Generalized Anxiety Disorder-7 score ≥10) are offered a six-week CONEMO app-based intervention supported by a WhatsApp chatbot and a monitoring dashboard for primary care professionals. Primary outcomes are implementation outcomes, including penetration, acceptability, feasibility, and safety, assessed using app usage data, self-report measures, and focus groups with users, health professionals, and managers. Secondary outcomes include changes in depression, anxiety, and insomnia symptoms, quality of life, and behavioral activation over 12 weeks. Quantitative data will be analyzed using mixed-effects models. No formal sample size calculation was performed because the intervention is offered to all eligible users in participating units. Discussion: Recruitment began in January 2026 and is expected to continue through December 2026. As of October 2026, approximately 400 participants had been enrolled, and the intervention was available in 21 primary care units across the 2 municipalities. Expansion to additional units in Jaguariúna is planned, with 28 units expected to participate. The study will generate evidence on the integration of a digital mental health intervention into routine primary care and identify barriers and facilitators to implementation and scale-up in Brazil. DECLARAÇÃO DE USO DE INTELIGÊNCIA ARTIFICIAL (IA): During the preparation of this work, the authors used Claude Haiku 5.5 (Anthropic), a generative artificial intelligence (AI) tool, to assist with organizing and formatting the references and revising the manuscript for adherence to the journal’s guidelines, including rewording sections. The authors reviewed and edited all AI-assisted content and take full responsibility for the content of the published article.
- 6 November 2026
- Published by FapUNIFESP (SciELO) in SciELO Preprints
Open AccessIntegrating a self-guided cognitive behavioral therapy app (CONEMO) into Brazilian primary health care: protocol for a hybrid type III implementation-effectiveness study
Background: Depression and anxiety are common and disabling mental health conditions. Although cognitive behavioral therapy (CBT) is an evidence-based treatment, access remains limited, particularly in low- and middle-income countries. Internet-delivered CBT (iCBT) may expand access to psychological interventions, but integrating digital interventions into routine primary care remains challenging. This study protocol describes the implementation of CONEMO (Emotional Control), a self-guided iCBT app for depression and anxiety symptoms, in primary care units in 2 municipalities in Brazil. Methods: This mixed-methods hybrid type III implementation-effectiveness study is being conducted in primary care units in Indaiatuba and Jaguariúna, São Paulo, Brazil. Adults screening positive for depression (Patient Health Questionnaire-9 score ≥10) or anxiety (Generalized Anxiety Disorder-7 score ≥10) are offered a six-week CONEMO app-based intervention supported by a WhatsApp chatbot and a monitoring dashboard for primary care professionals. Primary outcomes are implementation outcomes, including penetration, acceptability, feasibility, and safety, assessed using app usage data, self-report measures, and focus groups with users, health professionals, and managers. Secondary outcomes include changes in depression, anxiety, and insomnia symptoms, quality of life, and behavioral activation over 12 weeks. Quantitative data will be analyzed using mixed-effects models. No formal sample size calculation was performed because the intervention is offered to all eligible users in participating units. Discussion: Recruitment began in January 2026 and is expected to continue through December 2026. As of October 2026, approximately 400 participants had been enrolled, and the intervention was available in 21 primary care units across the 2 municipalities. Expansion to additional units in Jaguariúna is planned, with 28 units expected to participate. The study will generate evidence on the integration of a digital mental health intervention into routine primary care and identify barriers and facilitators to implementation and scale-up in Brazil. DECLARAÇÃO DE USO DE INTELIGÊNCIA ARTIFICIAL (IA): During the preparation of this work, the authors used Claude Haiku 5.5 (Anthropic), a generative artificial intelligence (AI) tool, to assist with organizing and formatting the references and revising the manuscript for adherence to the journal’s guidelines, including rewording sections. The authors reviewed and edited all AI-assisted content and take full responsibility for the content of the published article.
- Open Access
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 47 (AheadOfPri)
Is digital psychiatry really for all? A cross-sectional analysis from two randomized clinical trials
Trends Psychiatry Psychother, vol.0, nAheadOfPrint, p.0-0, 2024
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 47 (AheadOfPri)
Open AccessIs digital psychiatry really for all? A cross-sectional analysis from two randomized clinical trials
Trends Psychiatry Psychother, vol.0, nAheadOfPrint, p.0-0, 2024
- Open Access
- 1 January 2022
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 44 (6) , 621-627
Comorbidity of psychiatric and dermatologic disorders with skin picking disorder and validation of the Skin Picking Scale Revised for Brazilian Portuguese
Objective: Skin picking disorder (SPD) affects up to 5.4% of the population. Less than half of patients are correctly diagnosed and treated. Developing tools to recognize SPD can help professionals and patients alike. This trial aimed to validate the Skin Picking Scale-Revised (SPS-R) for the Brazilian population and assess the psychiatric and dermatological comorbidities of patients with SPD.Methods: Brazilians with a primary diagnosis of SPD, 18 years or older, were recruited from a community sample by media advertising and evaluated by a dermatologist and a psychiatrist. Self-report instruments were used: SPS-R, Dermatology Life Quality Index (DLQI), General Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9). Confirmatory factor analysis (CFA) was performed to evaluate the SPS-R, and Pearson correlation (r) was used to assess the relationship between instruments.Results: Overall, 124 patients were included. The SPS-R demonstrated good internal consistency (Cronbach's coefficient = 0.84). CFA found a good fit to the model according to all indices (?2 = 29.67; degrees of freedom [df] = 19; p = 0.056; root mean square error of approximation [RMSEA] = 0.067; comparative fit index [CFI] = 0.969; non-normed fit index [NNFI] = 0.954). SPS-R correlated with DLQI (r = 0.73), GAD-7 (r = 0.51), and PHQ-9 (r = 0.43). The sample had a high prevalence of psychiatric disorders, mainly generalized anxiety disorder (62.1%) and current (32.3%) and past (37.1%) depressive episodes.Conclusion: The Brazilian version of the SPS-R presents good psychometric properties. The severity of SPD is related to severity of depression, anxiety, and impairment in quality of life.Clinical trial registration: ClinicalTrials.gov, NCT04731389
- 1 January 2022
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 44 (6) , 621-627
Open AccessComorbidity of psychiatric and dermatologic disorders with skin picking disorder and validation of the Skin Picking Scale Revised for Brazilian Portuguese
Objective: Skin picking disorder (SPD) affects up to 5.4% of the population. Less than half of patients are correctly diagnosed and treated. Developing tools to recognize SPD can help professionals and patients alike. This trial aimed to validate the Skin Picking Scale-Revised (SPS-R) for the Brazilian population and assess the psychiatric and dermatological comorbidities of patients with SPD.Methods: Brazilians with a primary diagnosis of SPD, 18 years or older, were recruited from a community sample by media advertising and evaluated by a dermatologist and a psychiatrist. Self-report instruments were used: SPS-R, Dermatology Life Quality Index (DLQI), General Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9). Confirmatory factor analysis (CFA) was performed to evaluate the SPS-R, and Pearson correlation (r) was used to assess the relationship between instruments.Results: Overall, 124 patients were included. The SPS-R demonstrated good internal consistency (Cronbach's coefficient = 0.84). CFA found a good fit to the model according to all indices (?2 = 29.67; degrees of freedom [df] = 19; p = 0.056; root mean square error of approximation [RMSEA] = 0.067; comparative fit index [CFI] = 0.969; non-normed fit index [NNFI] = 0.954). SPS-R correlated with DLQI (r = 0.73), GAD-7 (r = 0.51), and PHQ-9 (r = 0.43). The sample had a high prevalence of psychiatric disorders, mainly generalized anxiety disorder (62.1%) and current (32.3%) and past (37.1%) depressive episodes.Conclusion: The Brazilian version of the SPS-R presents good psychometric properties. The severity of SPD is related to severity of depression, anxiety, and impairment in quality of life.Clinical trial registration: ClinicalTrials.gov, NCT04731389
- Open Access
- 1 January 2022
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 44 (6) , 1-6
Is the PHQ-9 item of suicide thoughts good enough to detect clinical risk of suicide in workers from essential services seeking emotional support during the COVID-19 pandemic?
- 1 January 2022
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 44 (6) , 1-6
Open AccessIs the PHQ-9 item of suicide thoughts good enough to detect clinical risk of suicide in workers from essential services seeking emotional support during the COVID-19 pandemic?
- 9 July 2020
- Published by Taylor & Francis in Issues in Mental Health Nursing
- Vol. 42 (2) , 112-118
Anxiety Sensitivity and Panic Disorder: Evaluation of the Impact of Cognitive-Behavioral Group Therapy
Anxiety sensitivity (AS) is a multidimensional construct associated with the etiology and maintenance of panic disorder (PD) symptoms. However, only a few studies have evaluated whether cognitive-behavioral group therapy (CBGT) can modify the condition. The objective of this study was to evaluate the impact of CBGT on AS in patients with PD and to analyze AS and its dimensions as predictors of response to CBGT. In the present clinical trial, an intervention group (n = 37) attended 12 CBGT sessions, while a control group (n = 52) did not receive any intervention. The severity of symptoms and of AS were evaluated before and after CBGT in the intervention group and once in the control group. Significant improvement occurred in all specific PD symptoms and in general anxiety and depressive symptoms. Furthermore, AS scores reduced significantly after intervention. This study confirmed that AS is higher in patients with more severe PD. The effectiveness of CBGT for reducing the physical, cognitive, and social dimensions of AS was also observed, supporting the hypothesis of a positive impact of therapy.
- 9 July 2020
- Published by Taylor & Francis in Issues in Mental Health Nursing
- Vol. 42 (2) , 112-118
Anxiety Sensitivity and Panic Disorder: Evaluation of the Impact of Cognitive-Behavioral Group Therapy
Anxiety sensitivity (AS) is a multidimensional construct associated with the etiology and maintenance of panic disorder (PD) symptoms. However, only a few studies have evaluated whether cognitive-behavioral group therapy (CBGT) can modify the condition. The objective of this study was to evaluate the impact of CBGT on AS in patients with PD and to analyze AS and its dimensions as predictors of response to CBGT. In the present clinical trial, an intervention group (n = 37) attended 12 CBGT sessions, while a control group (n = 52) did not receive any intervention. The severity of symptoms and of AS were evaluated before and after CBGT in the intervention group and once in the control group. Significant improvement occurred in all specific PD symptoms and in general anxiety and depressive symptoms. Furthermore, AS scores reduced significantly after intervention. This study confirmed that AS is higher in patients with more severe PD. The effectiveness of CBGT for reducing the physical, cognitive, and social dimensions of AS was also observed, supporting the hypothesis of a positive impact of therapy.
- Open Access
- 1 September 2019
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 94 (5) , 553-560
Melhorando o diagnóstico de dermatotilexomania entre brasileiros: validação da Escala de Impacto de Dermatotilexomania e desenvolvimento de uma medida fotográfica
- 1 September 2019
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 94 (5) , 553-560
Open AccessMelhorando o diagnóstico de dermatotilexomania entre brasileiros: validação da Escala de Impacto de Dermatotilexomania e desenvolvimento de uma medida fotográfica
- Open Access
- 1 September 2019
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 94 (5) , 553-560
Improving skin picking diagnosis among Brazilians: validation of the Skin Picking Impact Scale and development of a photographic instrument
- 1 September 2019
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 94 (5) , 553-560
Open AccessImproving skin picking diagnosis among Brazilians: validation of the Skin Picking Impact Scale and development of a photographic instrument